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ABSTRACT 
Selective side-chain residue flexibility is an option available on AutoDock Vina 
docking software. This approach is promising as it attempts to provide a more realistic 
ligand-protein interaction environment, without an unmanageable increase in computer 
processing time. However, studies validating this approach are still scarce. VEGFR-2 
(vascular endothelial growth factor receptor 2), a known protein target for anti-
angiogenic agents, was used in this study. Four residues present in the VEGFR-2 kinase 
site were selected and made flexible: Lys866, Glu885, Cys917 and Asp1044. The 
docking scores for all possible combinations of flexible residues were compared to the 
docking scores using a rigid conformation. The best overall docking scores were 
obtained using the Glu883 flexible conformation, with pearson and spearman rank 
correlation values of 0.568 and 0.543, respectively, and a 51% increase in computer 
processing time. Using different VEGFR-2 X-ray structures a similar trend was 
observed with Glu885 flexible conformation presenting the best scores. This study 
demonstrates that careful use of selective side-chain residue flexibility can improve 
AutoDock Vina docking score accuracy, without a significant increase in computer 
processing time. This methodology proved to be a valuable tool in drug design when 
using VEGFR-2 but will also probably be useful if applied to other protein targets. 
Introduction  
 
Angiogenesis is the process of new blood vessel formation from pre-existing 
vascular networks by capillary sprouting (1) and plays an important role in the 
pathogenesis of several disorders including cancer, proliferative retinopathies and 
rheumatoid arthritis (2). A key regulatory pathway of angiogenesis is mediated by the 
vascular endothelial growth factor (VEGF) and its cell membrane tyrosine kinase 
receptor VEGFR-2 (also know as KDR kinase) (3). Several VEGFR-2 inhibitors have 
emerged as promising anti-angiogenic agents for possible treatment against a wide 
variety of cancers. Sorafenib (Bay 43-9006), sunitinib (SU-11248) and pazopanib 
(GW786034) are VEGFR-2 inhibitors that have been approved for the treatment of 
advanced renal cell carcinoma (4).  
Molecular docking (henceforth referred as docking) and virtual screening are 
structure-based drug design (SBDD) methods routinely used in modern drug discovery 
(5). The existence of VEGFR-2 kinase domain crystal structures enabled the use of 
SBDD tools to investigate new potential inhibitors. Several studies have been published 
with modeling studies using VEGFR-2 structures, mostly developing pharmacophore 
based 3D-QSAR models in order to predict the activity of new synthesized compounds 
(6-9). However the use of docking has been limited to pose inspection of known 
inhibitors and not to predict VEGFR-2 inhibition activity of small compounds. This is 
probably because, despite its potential for a wide range of applications, docking 
continues to face methodological issues and is still not considered accurate enough for 
virtual screening, as recently reported by Plewczynski et al. (10). Probably the most 
notable difficulty of current docking applications is the use of rigid receptor 
conformations. Receptor flexibility is still a difficult problem due to the computational 
challenges posed by the numerous degrees of freedom involved in incorporating protein 
flexibility when performing docking (11). In fact, it has been shown that, when only a 
rigid receptor conformation is considered, state-of-the-art docking algorithms predict 
incorrect binding pose for about 50–70% of all ligands (12). Several docking programs 
are currently available including DOCK, FlexX, GOLD, AutoDock4 and AutoDock 
Vina, just to name the more widely used (10). Most of these programs can model full 
ligand flexibility but only a few take receptor flexibility into account and even then only 
to a limited extent (13).  
In the present work AutoDock Vina (henceforth referred to as ADVina), a freely 
available program for academic and commercial applications, was used. ADVina 
provides some degree of protein flexibility by allowing predefined residue side-chains 
to be flexible during docking (14). An analysis of VEGFR-2 selective residue side-chain 
flexibility was performed using this program. A dataset of 123 compounds with known 
VEGFR-2 inhibition activity was used and the Glu885 flexible conformation provided 
the best results with a significant docking score accuracy improvement over the rigid 
conformation. A demonstration that Glu885 flexibility improves scoring accuracy is 
also provided, even when using different VEGFR-2 X-ray structures. This work proves 
that a careful selection of residue side-chain flexibility may improve robustness of 
ADVina docking scores, without an unmanageable increase in computer processing 
time. 
Methods and Materials 
 
Dataset of VEGFR-2 inhibitors 
A dataset of 123 compounds, covering four log units (pIC50 = 5.66–9.70) of 
VEGFR-2 inhibitory activity, was taken from the literature (15-18) (experimental IC50 
values for the 123 compounds are available in the results.xls file as supporting 
information). The 2D structures of the dataset compounds were drawn using 
ACD/ChemSketch Freeware 12.0 software (19). VegaZZ 2.3.1 (20) software was then 
used to: convert 2D structures to 3D structures, perform energy minimization and record 
files in PDB format. AutoDockTools1.5.2 (ADT) (21) was then used to merge nonpolar 
hydrogens, add gasteiger charges, and set up rotatable bonds. Finally all ligands were 
recorded in the PDBQT file format used by ADVina (structures in SDF format of the 
123 dataset compounds are available in the dataset.sdf file as supporting information). 
 
Preparation of VEGFR-2 flexible conformations 
All VEGFR-2 X-ray crystal structures used were extracted from the Protein Data 
Bank (PDB): 1YWN, 3BE2, 3EWH and 2P2H. Flexible conformations of VEGFR-2 
were prepared using the respective crystal structure. The software AutoDockTools was 
used to extract the co-crystallized ligands from the PDB files, assign polar hydrogens, 
add gasteiger charges, select the flexible residues side-chains and save the structures in 
PDBQT file format required to use ADVina. 
 
Docking with ADVina 
ADVina 1.0.2 (14) was used to perform docking using all the 15 VEGFR-2 flexible 
conformations and the rigid conformation. A docking grid with a size of 24 Åx24 Åx24 
Å and centred on the coordinates x=1.361, y= 38.562, z= 14.311 was used. The centre 
coordinate was obtained form the central atom of the co-crystallized inhibitor of each 
PDB structure. The grid size was selected in order to encompass the co-crystallized 
inhibitors plus 15 Å on each direction. Due to the large number of docking runs, MOLA 
software (22) was used to automate all docking runs using a 8 Intel Dual-Core 2.8 GHz 
computer cluster. ADVina scoring function presents the results as free energy of 
binding (∆G). The predicted inhibition constant (predicted Ki) for all docking runs was 
calculated from the ∆G value as follows: Ki = exp((∆G*1000)/(Rcal*TK)) where Rcal 
is 1.98719 and TK is 298.15 (the predicted Ki values are presented in the results.xls file 
as supporting information). The R statistical software (23) and the R Commander 
graphical user interface (24) were used to calculated the Pearson and Spearman rank 
correlations by comparing the experimental IC50 values with the predicted Ki docking 
scores (Table 1). All the figures with structure representations were produced using the 
PyMOL software (2Results and Discussion 
 
Selection of VEGFR-2 flexible residues 
A statistical analysis of the PDB databank revealed that 85% of proteins contain 
one to three flexible residues in the active site (26), and the inability to consider this 
flexibility is probably related to the limitations of the flexible ligand-rigid receptor 
approach. ADVina docking tool provides the possibility to select specific residues as 
flexible, allowing rotation around torsional degrees of freedom (27). In this work, we 
set out to analyze if the flexibility options on ADVina can improve docking accuracy 
using VEGFR-2 as protein target. VEGFR-2 can be considered as a good candidate for 
this type of flexibility study as VEGFR-2 structure presents a relatively rigid 
conformation when comparing the available X-ray structures. Furthermore, VEGFR-2 
does not engage in any major conformational alterations when binding to different 
known inhibitors (Figure 1). 
By comparing the kinase binding pocket of different VEGFR-2 crystal 
structures, we started by selecting residues with some degree of cross-structure 
flexibility (Figure 1). The main issue to be aware of at this stage is an increase in 
degrees of freedom, resulting in more computational time need to perform the docking 
runs (table 1). From our experience using ADVina, flexibilizing many residue side-
chains can result in unpredictable results as it tends to introduce a bias towards lower 
energies of binding, with a consequent increase in false positives. Also, more flexible 
residue side-chains results in an increase in the computational processing time need to 
perform the docking runs. Taken these factors into account, a maximum of 4 flexible 
residue side-chains was established. After inspecting the kinase active site of several 
VEGFR-2 structures, 4 residues were selected: Lys868, Glu885, Cys919 and Asp1046. 
As can be seen by the superimposition of 4 VEGFR-2 crystal structures, the selected 
residues present some degree of flexibility (Figure 1). Also these residues interact 
consistently, by forming hydrogen bonds (H-bonds) with the inhibitors that are co-
crystallized in the inspected VEGFR-2 structures.  
After an extensive survey of the available PDB structures, the VEGFR-2 crystal 
structure PDB:1YWN was selected (28). This structure was chosen as it presents low 
resolution (1.72 A) and has been consistently used in several SBDD studies (6,7). 
Furthermore, the co-crystallized inhibitor 4-amino-furo[2,3-d]pyrimidine interacts with 
all the selected residues (Figure 1).  
 
Evaluation of ADVina scoring using VEGFR-2 rigid and flexible conformations 
A standard docking study yields two main results: a docking pose of the 
interaction between the ligand and the protein target, and a docking score that estimates 
the strength of the protein–ligand interaction. This study focuses on the docking score 
element and evaluates if VEGFR-2 residue side-chain flexibilization is able to produce a 
significant enrichment in ADVina scoring. A dataset of 123 compounds, with known 
VEGFR-2 inhibition activity spanning 4 orders of magnitude, was docked against the 
rigid conformation and against 15 combinations of VEGFR-2 flexible residue side-
chains conformations (flexible conformations). The docking scores were then compared 
and correlated with the experimental binding affinity values of the dataset (Table 1). 
The docking score enrichment was evaluated using several parameters: pearson 
correlation, spearman rank correlation and docking computational processing time. 
Especially in virtual screening, the spearman rank correlation is an important statistical 
parameter as the position of the compounds within an ordered list is usually more 
valuable information than the actual docking scores. As more flexible residues are 
selected, the time need to perform the docking runs should be taken in consideration as 
there is an increase in the number of rotatable bonds and consequent increase in 
computational processing time (Table 1). 
The pearson and spearman rank coefficients obtained using the rigid 
conformation were 0.223 and 0.456, respectively. These values are in agreement with a 
recent study using different proteins and docking softwares (10), were eHits software 
(averaging the results for all the proteins used in the study) was the top performer, with 
pearson and spearman rank coefficients of 0.380 and 0.470, respectively. When using 
single flexible residue side-chain conformations, the Glu885 flexible conformation 
presented the best scores with a sharp pearson coefficient increase (0.568) and a 
significant spearman rank coefficient increase (0.543). As expected, due to an increase 
in three rotatable bonds, the Glu885 flexible conformation resulted in a 51 % increase in 
processing time (table 1). Single Lys868, Cys919 or Asp1046 flexible conformations 
did not produce a consistent increase in scoring enrichment. When using two, three or 
all four flexible residue side-chain conformations, only conformations including the 
flexible Glu885 improved pearson or spearman rank correlations. The Lys868-Glu885 
flexible conformation presented higher pearson correlation (0.634) but lower spearman 
rank correlation (0.417), while Glu885-Cys919 flexible conformation presented higher 
spearman rank correlation (0.580) but lower pearson correlation (0,560), although with 
a 112% increase in processing time. Of note is that the all four residue flexible 
conformation presented lower spearman rank coefficients (0,436) when compared to the 
rigid conformation. This analysis demonstrates that careful selection of flexible residue 
side-chains can increase the quality of ADVina docking scoring, with an acceptable 
payoff in processing time. Nevertheless, a blind increase in the number of flexible 
residue side-chains does not translate into an automatic increase in ADVina docking 
score enrichment. In fact, the results confirm our earlier impression when using 
ADVina that, as the number of flexible residue side-chains increase, there is a threshold 
where the quality of the docking scores does not increase or even decrease. This is 
probably due to an increase in false positives as a consequence of an easier 
accommodation of compounds made possible by the flexible residue side-chains. 
Although this work has been performed using VEGFR-2, we believe that this flexible 
docking methodology can be applied using other protein targets to improve docking 
poses and docking scores. 
 
Table 1. Results for ADVina scoring using rigid and flexible conformations. 
Flexible  
Side-Chain Residues 
Pearson 
Correlation  
Spearman Rank 
Correlation 
Spearman 
p-value 
Processing 
Time % (a) 
Rotatable 
bonds 
RIGID 0,23 0,456 1,13E-007 100 0 
ASP 0,219 0,381 1,39E-005 154 2 
CYS 0,389 0,421 1,22E-006 126 1 
LYS 0,307 0,356 5,36E-005 232 4 
GLU 0,568 0,543 8,78E-011 151 3 
ASP CYS 0,201 0,247 0.005914 147 3 
ASP LYS 0,352 0,335 0.0001488 327 6 
ASP GLU 0,410 0,555 2,68E-011 258 5 
CYS LYS 0,204 0,322 0.0002823 275 5 
CYS GLU 0,560 0,584 1,28E-012 212 4 
LYS GLU 0,634 0,477 2,52E-008 378 7 
CYS LYS GLU 0,549 0,531 2,68E-010 437 8 
ASP LYS GLU 0,249 0,525 4,65E-010 525 9 
ASP CYS GLU 0,518 0,427 8,65E-007 311 6 
ASP CYS LYS 0,315 0,293 0.001023 374 7 
ASP CYS LYS GLU 0,350 0,436 4,56E-007 616 10 
(a) Average processing time for the rigid conformation was 1 minute per ligand that corresponds to 100% 
processing time. 
 
To investigate if flexible Glu885 docking scores improvement was independent 
of the crystal structure used, the same methodology was applied to 3 different VEGFR-
2 crystal structures available: 2P2H, 3BE2 and 3EWH (Table 2). The structures were 
selected according to: structure resolution (lower than 2 Å) and presence of different 
inhibitors. In all crystal structures used, a consistent improvement in pearson and 
spearman rank correlations was observed when using the Glu885 flexible conformation 
compared to the rigid conformation (Table 2). On the other hand, no consistent trend 
was observed with Glu885-Cys919 and Glu885-Lys868 flexible conformations. In fact 
all structures presented lower pearson and spearman rank correlation, with the notable 
exception of Glu885-Lys868 flexible conformations when using the 3BE2 structure. 
This study demonstrates that the Glu885 flexible conformation provides the best overall 
docking scores, using less computer processing time and in a crystal structure 
independent manner. 
 
Table 2. Results for ADVina scoring using different VEGFR-2 X-ray structures: 1YWN, 2P2H, 3BE2 
and 3EWH; and different flexible residue conformations: Rigid, GLU and Glu885-Cys919 and 
Glu885-Lys868 flexible conformations in. 
  Pearson Correlation Spearman Correlation 
PDB 
entry Rigid GLU 
GLU 
CYS 
GLU 
LYS Rigid GLU 
GLU 
CYS 
GLU 
LYS 
1YWN 0,230 0,568 0,560 0,634 0,456 0,543 0,584 0,477 
2P2H 0,342 0,51 0,476 0,266 0,296 0,382 0,374 0,197 
3BE2 0,466 0,498 0,472 0,53 0,421 0,467 0,438 0,542 
3EWH 0,256 0,625 0,522 0,372 0,469 0,514 0,507 0,449 
 
 Figure 2. Docking pose superimposition of two dataset compounds, (a) A8 and (b) 
A117, using the rigid (yellow) and Glu885 flexible (green) VEGFR-2 conformations. 
H-bonds represented in traced green.  
To better understand the scoring enrichment promoted by flexibilization of 
Glu885, docking pose inspections of the dataset compounds were performed. In general 
it was observed that Glu883 flexibilization improved docking score accuracy by 
enabling compounds to completely enter the VEGFR-2 kinase binding pocket. This was 
made possible by the accommodation of the Glu883 side-chain and, in almost all cases, 
by the formation of new H-bonds. Figure 2 shows two representative dataset 
compounds, A8 and A117, were Glu885 flexibilization enabled the positioning of both 
compounds completely inside the VEGFR-2 binding pocket. These compounds 
represent the two different H-bonds configurations observed in the dataset: an H-bond 
between the compounds and the amino group of the rigid Lys868 side-chain (Fig. 2a), 
or an H-bond between the compounds and the carboxyl group of the flexible Glu885 
(Fig. 2b). 
 
Conclusions and future work 
In this work, a docking study of selective residue side-chain flexibility was performed 
using the tyrosine kinase receptor VEGFR-2 as protein target, and ADVina as docking 
software. It was demonstrated that an important docking score improvement can be 
obtained with careful binding site analysis and selection of relevant residues. The 
Glu885 flexible conformation provided the best docking scores and this improvement 
was observed across all the X-ray structures used. This methodology may be a valuable 
tool in drug design when performing virtual screening, either using VEGFR-2 or 
applied to other therapeutic protein targets. To our knowledge it is the first time that an 
in-depth receptor-flexibility docking study software was performed using ADVina. 
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Figures 
Figure 1. Superimposition of the VEGFR-2 selected residues from 4 crystal structures: 
1YWN (sticks and balls representation), 3BE2, 3EWH, 2P2H (line representation). 
Light grey the cartoon representation of 1YWN, line green the 1YWN co-crystallized 
ligand. 
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Additional Supporting Information may be found in the online version of this article: 
 
File dataset.sdf. Chemical structures of all the 123 known VEGFR-2 inhibitors in the 
dataset, provided in SDF file format. 
 
File results.xls. Spreadsheet presenting the experimental IC50 of all the 123 known 
VEGFR-2 inhibitors in the dataset. The predicted Ki of the dataset compounds for the 
fifteen flexible conformations and the rigid conformation are also presented.  
